Pharmacometrics in tuberculosis: progress and opportunities
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference103 articles.
1. Global tuberculosis report 2021,2021
2. Four-month rifapentine regimens with or without moxifloxacin for tuberculosis;Dorman;N Engl J Med,2021
3. The treatment of tuberculosis;Peloquin;Clin Pharmacol Ther,2021
4. A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis;Boeree;Am J Respir Crit Care Med,2015
5. High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial;Boeree;Lancet Infect Dis,2017
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Application of MIDD to accelerate the development of anti-infectives: Current status and future perspectives;Advanced Drug Delivery Reviews;2024-09
2. Screening of drug targets for tuberculosis on the basis of transcription factor regulatory network and mRNA sequencing technology;Frontiers in Molecular Biosciences;2024-05-22
3. Predicting over-the-counter antibiotic use in rural Pune, India, using machine learning methods;Epidemiology and Health;2024-04-13
4. Push forward LC-MS-based therapeutic drug monitoring and pharmacometabolomics for anti-tuberculosis precision dosing and comprehensive clinical management;Journal of Pharmaceutical Analysis;2024-01
5. Predicting early bactericidal activity using pre-clinical data for tuberculosis drugs: a platform for model-informed drug discovery and development;European Respiratory Journal;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3